David Miller

18PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyInteractive narrativeMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 20, 2026
Frontline immunotherapy with response-guided subsequent treatment (FIRST) in cutaneous squamous cell carcinoma: a Bayesian causal analysis of dose intensity, early benefit, and treatment de-escalation.

|Apr 13, 2026
Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF-mutant advanced melanoma: A matching-adjusted indirect comparison.

David M Miller, James W Smithy, Jennell Palaia

|May 02, 2024
The prognostic value of the Merkel cell polyomavirus serum antibody test: A dual institutional observational study.

David M Miller, Sophia Z Shalhout, Kayla M Wright

|Mar 01, 2023
Skin-Cancer Chemoprevention in Transplant Recipients.

David M Miller, Kevin S Emerick

|Jan 12, 2023
StoryboardR: an R package and Shiny application designed to visualize real-world data from clinical patient registries.

David M Miller, Sophia Z Shalhout

|Jan 11, 2023
Therapy with oncolytic viruses: progress and challenges.

Sophia Z Shalhout, David M Miller, Kevin S Emerick

Pageof 3

Frequent Collaborators

10 joint publications

Sophia Z Shalhout

2 joint publications

Ann W Silk

1 joint publications

Farees Saqlain

1 joint publications

Keith T Flaherty